PUBLISHER: GlobalData | PRODUCT CODE: 1095102
PUBLISHER: GlobalData | PRODUCT CODE: 1095102
Disposable Endoscopes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Endoscopy Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Disposable Endoscopes market for the year 2020 and beyond. Disposable endoscopes are used in a variety of diagnostic and therapeutic procedures, depending upon the specific type of endoscope under review. Diseases that may occur ubiquitously, such as cancer, can be detected by almost any type of disposable endoscopes, while site-specific diseases or conditions would only be detected by a specific type. The emerging market for disposable endoscopes is one that is rapidly growing, with new types of disposable endoscopes and manufacturers entering the market every year such as disposable duodenoscopes that have only been approved for use since late 2019. As the market for disposable endoscopes continues to rapidly rise, it will simultaneously replace the reusable endoscopes market mainly due to their higher average selling prices and maintenance costs.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Disposable Endoscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Ambu A/S, Boston Scientific Corp, Coloplast A/S, KARL STORZ SE & Co KG, Meditrina Inc, Roper Technologies Inc, NeoScope Inc, The Cooper Companies Inc, Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -